Cargando…
Recent advances in the understanding of the molecular pathogenesis and targeted therapy options in Langerhans cell histiocytosis
Langerhans cell histiocytosis (LCH) is the most common histiocytic disorder caused by the clonal expansion of myeloid precursors that differentiate into CD1a+/CD207+ cells in the lesion. Advances in genomic sequencing techniques have improved our understanding of the pathophysiology of LCH. Activati...
Autores principales: | Suh, Jin Kyung, Kang, Sunghan, Kim, Hyery, Im, Ho Joon, Koh, Kyung-Nam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093998/ https://www.ncbi.nlm.nih.gov/pubmed/33935037 http://dx.doi.org/10.5045/br.2021.2021013 |
Ejemplares similares
-
Role of p16 in the pathogenesis of Langerhans cell histiocytosis
por: Kim, Sun-Young, et al.
Publicado: (2010) -
Langerhans cell histiocytosis: current advances in molecular pathogenesis
por: Sconocchia, Tommaso, et al.
Publicado: (2023) -
Prognostic significance of gelsolin and MMP12 in Langerhans cell histiocytosis
por: Seo, Jong-Jin, et al.
Publicado: (2012) -
Long-term treatment outcomes of children and adolescents with lymphoblastic lymphoma treated with various regimens: a single-center analysis
por: Choi, Ho Jung, et al.
Publicado: (2020) -
New clinical score for disease activity at diagnosis in Langerhans cell histiocytosis
por: Choi, Won-ik, et al.
Publicado: (2011)